Cresilon
NY - BrooklynBiotechnology
Focus: Cresilon is a Brooklyn-based biotechnology company specializing in hemostatic gel technology for ophthalmology and neurology applications. The company operates at a pre-commercial or early-stage scale with limited public financial disclosure.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Open Jobs
7
Should You Work at Cresilon?
AI assessmentCresilon is a high-risk, high-impact early-stage bet suited to scientists seeking deep technical involvement in a novel platform, but unsuitable for those prioritizing stability, transparent milestones, or near-term revenue upside.
Why Work Here
- Join a focused biotech with a novel, differentiated product (hemostatic gel) in high-impact surgical specialties with unmet clinical needs.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cresilon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.